Clinical Trial Update: A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a botanical product containing East Indian Sandalwood Oil for atopic dermatitis has been withdrawn. Sponsor: Santalis Pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• East Indian Sandalwood Oil (EISO) (East Indian Sandalwood Oil)

Snippet

Sponsor: Santalis Pharmaceuticals, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: WITHDRAWN